One Gene, Two States: Truncating Loss Versus Retained Full-Length p53 in Solid and Hematologic Cancers
- 1Department of Hematologic Oncology, Guangxi Medical University Cancer Hospital, Nanning 530200, China
Abstract
TP53 mutations create two functionally opposite states—loss of the protein or retention of a full-length mutant protein—yet are usually reported as one entity. How the two states are distributed between solid tumors and hematologic malignancies has not been quantified. In one pipeline integrating ≈64,000 samples (29 solid-tumor types, 19 hematologic cohorts and a 42,714-sample post-therapy clonal-hematopoiesis cohort), we asked which state is selected where, what it does, and what it offers. Truncating mutations accounted for 34.2% of solid but 24.4% of hematologic alterations (χ2 = 33.7, p = 2.3 × 10−7; reproduced in the NCI TP53 and COSMIC databases). Where copy number resolves allelic state, 60.6% of missense-mutant solid tumors had lost the wild-type allele (19.5% biallelic inactivation). Blood retained full-length missense protein instead, and in MDS, outcome tracked the retained-allele dose (hazard ratio 1.78, p = 1.0 × 10−4); in solid tumors, no survival difference was detected by allelic state. The endogenous CpG baseline is equivalent (20.7% versus 21.2%), while solid spectra carry exogenous exposure fingerprints. Only the retained state presents a target, so allele-specific reactivation is the rational corollary where retention prevails—a hypothesis, as retention in blood is inferred from mutation class.
Related
- Co-retained intron retention on single RNA molecules marks fitness-critical genes
- A Study on Secondary Subfertility Caused by a Retained Intrauterine Foreign Body: Unveiling a Decade-Long Clinical Enigma.
- Dual-Loaded Quercetin-Resveratrol Niosomes: Sustained In Vitro Release and Retained Bioactivity in Hummus During Simulated Gastrointestinal Digestion.
- Disease-specific gut microbiota–metabolite–immune networks in hematologic disorders: mechanisms, causal support, and translational strategies
- Ribosome biogenesis and selective translational control as oncogenic vulnerabilities in hematologic malignancies.
BibTeX
@article{huang2026gene,
title = {{One Gene, Two States: Truncating Loss Versus Retained Full-Length p53 in Solid and Hematologic Cancers}},
author = {Haichun Huang and Yikui Xie and Baoping Guo and Ying Duan and Hong Cen},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272110024},
url = {https://www.mdpi.com/1422-0067/27/21/10024},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - One Gene, Two States: Truncating Loss Versus Retained Full-Length p53 in Solid and Hematologic Cancers
AU - Haichun Huang
AU - Yikui Xie
AU - Baoping Guo
AU - Ying Duan
AU - Hong Cen
PY - 2026
DA - 2026/11/09
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272110024
UR - https://www.mdpi.com/1422-0067/27/21/10024
AB - TP53 mutations create two functionally opposite states—loss of the protein or retention of a full-length mutant protein—yet are usually reported as one entity. How the two states are distributed between solid tumors and hematologic malignancies has not been quantified. In one pipeline integrating ≈64,000 samples (29 solid-tumor types, 19 hematologic cohorts and a 42,714-sample post-therapy clonal-hematopoiesis cohort), we asked which state is selected where, what it does, and what it offers. Truncating mutations accounted for 34.2% of solid but 24.4% of hematologic alterations (χ2 = 33.7, p = 2.3 × 10−7; reproduced in the NCI TP53 and COSMIC databases). Where copy number resolves allelic state, 60.6% of missense-mutant solid tumors had lost the wild-type allele (19.5% biallelic inactivation). Blood retained full-length missense protein instead, and in MDS, outcome tracked the retained-allele dose (hazard ratio 1.78, p = 1.0 × 10−4); in solid tumors, no survival difference was detected by allelic state. The endogenous CpG baseline is equivalent (20.7% versus 21.2%), while solid spectra carry exogenous exposure fingerprints. Only the retained state presents a target, so allele-specific reactivation is the rational corollary where retention prevails—a hypothesis, as retention in blood is inferred from mutation class.
SN - 1422-0067
ER -